SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
SulAmérica is one of the largest insurance companies in Brazil and operates in the health and dental insurance, life and pension plans, and asset management sectors. The company was founded in 1895 and is headquartered in Rio de Janeiro, Brazil.
Rede D’Or is the largest integrated healthcare network in Brazil, operating in the health sector, with an extensive network of private hospitals.
One of Oaklins’ teams in Brazil acted as the sole financial advisor to SulAmérica on its combination with Rede D’Or São Luiz S.A. The transaction will be submitted for approvals at shareholders’ meetings of both companies and to relevant regulatory agencies. Once the closing date is defined the companies will inform the market.
Talk to the deal team
Richard Rainer
Oaklins Olimpia Partners
Related deals
Rare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreCenterbridge Partners has announced a minority interest investment in Pure Cremation
Centerbridge Partners, L.P. has announced a structured minority interest investment in Pure Cremation. The investment includes both loan and equity instruments and is subject to regulatory approval, with completion expected in the first half of 2026.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more